Unconfigured Ad

Collapse
X
Collapse
 
  • Page of 1
  • Time
  • Show
Clear All
new posts
Previous template Next
  • SylvainL
    Senior Member
    • Feb 2012
    • 180
    #1

    Illumina sues Oxford Nanopore

    Hi all,

    Illumina sues Oxford Nanopore...

    http://www.genomeweb.com/sequencing-...t-infringement

    Curious to have your opinion about this....
    Tags: None
    • NextGenSeq
      Senior Member
      • Apr 2009
      • 482
      #2
      Looks like ONT has become a threat.
      Illumina used to scoff at them.

      Competition is good for customers. Illumina is a one-trick pony and their technology is headed to the glue factory.

        Comment

        • narain
          Banned
          • Aug 2011
          • 73
          #3
          Patent fights converge to the more wealthy team as winner.

            Comment

            • Richard Finney
              Senior Member
              • Feb 2009
              • 701
              #4
              The patents in question as reported by BioIT World
              Illumina Sues Oxford Nanopore Technologies Over Composition of Nanopores
              http://www.bio-itworld.com/2016/2/24/illumina-sues-oxford-nanopore-technologies-over-composition-nanopores.html
              Discover the latest news in bioinformatics, biomedical research, and drug discovery. Bio-IT World provides topical news coverage and analysis of cutting-edge biotechnologies to deliver individualized medicine.


              US8673550B2 - MSP nanopores and related methods - Google Patents
              http://www.google.com/patents/US8673550
              Provided herein are Mycobacterium smegmatis porin nanopores, systems that comprise these nanopores, and methods of using and making these nanopores. Such nanopores may be wild-type MspA porins, mutant MspA porins, wild-type MspA paralog porins, wild-type MspA homolog porins, mutant MspA paralog porins, mutant MspA homolog porins, or single-chain Msp porins. Also provided are bacterial strains capable of inducible Msp porin expression.

              Mycobacterium smegmatis nanopores and related methods

              US9170230B2 - MSP nanopores and related methods - Google Patents
              http://www.google.com/patents/US9170230
              Provided herein are Mycobacterium smegmatis porin nanopores, systems that comprise these nanopores, and methods of using and making these nanopores. Such nanopores may be wild-type MspA porins, mutant MspA porins, wild-type MspA paralog porins, wild-type MspA homolog porins, mutant MspA paralog porins, mutant MspA homolog porins, or single-chain Msp porins. Also provided are bacterial strains capable of inducible Msp porin expression.

              MSP nanopores and related methods

                Comment

                • Brian Bushnell
                  Super Moderator
                  • Jan 2014
                  • 2709
                  #5
                  Originally posted by SylvainL View Post
                  Illumina sues Oxford Nanopore...
                  Booo...

                  Hopefully the fact that they are not a US company will shield them somewhat.

                    Comment

                    • dannyhi321
                      Member
                      • Jul 2014
                      • 51
                      #6
                      Originally posted by narain View Post
                      Patent fights converge to the more wealthy team as winner.
                      That's blatantly not true, take the recent IBS V Illumina case as an example.

                      Ever heard of David V Goliath?

                        Comment

                        • ymc
                          Senior Member
                          • Mar 2010
                          • 496
                          #7
                          While it is likely that this is Illumina's tactic to stall or distract ONT, WashU being one of plaintiffs does give this claim a little bit of credibility.

                            Comment

                            • dannyhi321
                              Member
                              • Jul 2014
                              • 51
                              #8
                              Originally posted by Brian Bushnell View Post
                              Booo...

                              Hopefully the fact that they are not a US company will shield them somewhat.
                              I thought discrimination was not tolerated on this site!?

                                Comment

                                Previous template Next

                                Latest Articles

                                Collapse
                                • SEQadmin2
                                  Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
                                  by SEQadmin2



                                  CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

                                  Despite this, “CRISPR helped turn genome editing from a specialized technique into                                  ...
                                  07-31-2026, 11:01 AM
                                • SEQadmin2
                                  Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                                  by SEQadmin2


                                  Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                                  The systematic characterization of the human proteome has                                  ...
                                  07-20-2026, 11:48 AM
                                • SEQadmin2
                                  Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                                  by SEQadmin2



                                  Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                                  ...
                                  07-09-2026, 11:10 AM
                                View All

                                ad_right_rmr

                                Collapse

                                News

                                Collapse
                                Topics Statistics Last Post
                                Long-Read Sequencing Closes Decades-Old Gaps in the Medaka Genome by SEQadmin2
                                Started by SEQadmin2, 08-03-2026, 10:13 AM
                                0 responses
                                21 views
                                0 reactions
                                		 Last Post SEQadmin2
                                by SEQadmin2
                                08-03-2026, 10:13 AM  
                                New Genomic Method Uncovers Ancient Hominin DNA by SEQadmin2
                                Started by SEQadmin2, 07-31-2026, 02:55 AM
                                0 responses
                                35 views
                                0 reactions
                                		 Last Post SEQadmin2
                                by SEQadmin2
                                07-31-2026, 02:55 AM  
                                Study Captures the First Moments of DNA Replication by SEQadmin2
                                Started by SEQadmin2, 07-24-2026, 12:17 PM
                                0 responses
                                25 views
                                0 reactions
                                		 Last Post SEQadmin2
                                by SEQadmin2
                                07-24-2026, 12:17 PM  
                                Chemotherapy Leaves Detectable DNA Signatures in Childhood Tumors by SEQadmin2
                                Started by SEQadmin2, 07-23-2026, 11:41 AM
                                0 responses
                                21 views
                                0 reactions
                                		 Last Post SEQadmin2
                                by SEQadmin2
                                07-23-2026, 11:41 AM  
                                View All
                                Working...